サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1579662

獣医分子診断学の世界市場

Veterinary Molecular Diagnostics

出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
獣医分子診断学の世界市場
出版日: 2024年10月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

獣医分子診断学の世界市場は2030年までに9億8,420万米ドルに達する見込み

2023年に5億9,650万米ドルと推定される獣医分子診断学の世界市場は、2023年から2030年にかけてCAGR 7.4%で成長し、2030年には9億8,420万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機器＆ソフトウェアは、CAGR7.2％を記録し、分析期間終了時には3億4,280万米ドルに達すると予測されます。キット＆試薬セグメントの成長率は、分析期間でCAGR 8.3％と推定されます。

米国市場は1億5,670万米ドルと推定・予測、中国はCAGR11.0％で成長予測

米国の獣医分子診断学市場は、2023年に1億5,670万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2億3,890万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは11.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.9%と6.6%と予測されています。欧州では、ドイツがCAGR 4.6%で成長すると予測されています。

世界の獣医分子診断学市場- 主要動向と市場促進要因を探る

なぜ獣医分子診断学が動物の健康管理に革命を起こすのか？

獣医分子診断学は、分子レベルでの正確かつ迅速な病気の検出を可能にし、動物ヘルスケアにおける革新的なツールとして登場しました。しかし、このような診断法が現代の獣医療に欠かせないのはなぜでしょうか？獣医分子診断学は、動物の病原体、腫瘍、遺伝的疾患からDNAやRNAなどの遺伝物質を同定する高度な検査技術です。これらの検査にはポリメラーゼ連鎖反応（PCR）、リアルタイムPCR、次世代シークエンシング（NGS）、マイクロアレイなどがあり、病原体、遺伝子変異、バイオマーカーを高い感度と特異性で検出・定量することができます。病気の遺伝的基盤をターゲットにすることで、これらの診断により獣医師は早期に、多くの場合臨床症状が現れる前に病状を診断することができ、タイムリーな介入と治療のための重要な窓口を提供することができます。

獣医分子診断学の需要は、人獣共通感染症の蔓延、動物の慢性および感染性疾患の発生率の上昇、予防ヘルスケアへの関心の高まりによって牽引されています。これらの診断薬は、パルボウイルス、猫白血病、牛呼吸器疾患などの感染症の検出や、遺伝性疾患のトランスミッションを防ぐための繁殖プログラムにおける遺伝子スクリーニングに広く使用されています。分子診断学は、がん治療のための標的療法の指針となる特定の変異やバイオマーカーを同定するために使用されています。さらに、近縁の病原体を区別し、一度の検査で複数の病原体を検出できることから、分子診断学は、従来の検査法では不十分な複雑な症例において、好ましい選択肢となっています。ペットの飼い主、家畜管理者、獣医師がより正確で信頼性の高い診断ソリューションを求める中、獣医分子診断学は動物の健康管理においてますます中心的な役割を果たすようになってきています。

技術の進歩は獣医分子診断学の性能をどのように高めていますか？

獣医分子診断学市場は、これらの診断ツールの精度、スピード、アクセシビリティを向上させる重要な技術的進歩を経験してきました。しかし、これらの発展の原動力となっている主な技術革新とは何でしょうか？最もインパクトのある進歩の一つは、リアルタイムPCR（qPCR）技術の進化です。qPCRは、リアルタイムでDNAまたはRNA配列を増幅し定量化する能力により、迅速かつ高感度な結果を提供するため、動物用診断におけるゴールドスタンダードとなっています。最新のqPCRシステムはマルチプレックス機能を備えており、1つのサンプルから複数の病原体や遺伝子マーカーを同時に検出することができます。この技術革新により、納期が大幅に短縮され、複数の検査を行う必要がなくなったため、獣医師はより迅速かつ十分な情報に基づいた判断を下すことができるようになりました。さらに、自動サンプル調製システムの統合により、ワークフローが合理化され、人的ミスの可能性が減少し、検査結果の一貫性と信頼性が向上しました。

もうひとつの重要な技術革新は、次世代シーケンサー（NGS）技術の登場であり、これは獣医ゲノミクスの分野に革命をもたらしました。NGSでは、ゲノム全体、または対象とする領域の塩基配列を決定することで包括的な遺伝子解析が可能となり、複雑な遺伝形質、疾病メカニズム、微生物群集に関する洞察が得られます。この技術は、病原体の発見、抗菌剤耐性のモニタリング、がんの遺伝子型判定などの用途で、研究および臨床の場でますます使用されるようになっています。携帯型・ポイントオブケア型分子診断装置の開発により、これらの技術の利用範囲はさらに拡大し、獣医師は診療所、農場、現場など、現場で検査を実施できるようになった。これらの機器はユーザーフレンドリーに設計されており、最小限のトレーニングやインフラしか必要としないため、遠隔地や資源が限られた環境であっても高度な分子診断にアクセスすることができます。さらに、バイオインフォマティクスとデータ解析の進歩は、分子診断結果の解釈を強化し、より正確で実用的な洞察を可能にしています。これらの技術革新は、獣医分子診断学の性能と実用性を高め、現代の獣医学にとって不可欠なツールとなっています。

動物ヘルスケアにおける獣医分子診断学の普及を促進する市場動向とは？

獣医師、研究者、飼い主の進化するニーズと期待を反映し、いくつかの新たな市場動向が動物ヘルスケア分野での獣医分子診断学の採用を形成しています。最も顕著な動向の一つは、予防医療と疾病の早期発見への注目の高まりです。ペットの飼い主や家畜の管理者が早期診断の利点をより認識するようになるにつれ、症状が出たり他の動物に広がったりする前に、不顕性の段階で病気を検出できる診断ツールに対する需要が高まっています。高い感度と特異性を持つ獣医分子診断学はこの目的に適しており、感染症病原体、遺伝子疾患、がん細胞の早期同定を可能にします。この動向は、定期的な健康診断やウェルネス・プログラムが一般的になりつつあるコンパニオンアニマル・セクターにおいて特に顕著です。遺伝的素因や感染症を早期に発見する能力により、獣医師は的を絞った予防措置を実施し、個別化された治療計画を立てることができ、健康状態の改善と長期的な治療費の削減が可能になります。

獣医分子診断学の導入を促進するもう1つの重要な動向は、人獣共通感染症の流行の高まりと、効果的な疾病サーベイランスの必要性です。動物と人間の間で感染する人獣共通感染症は、公衆衛生上の重大なリスクであり、発生を抑制し、種を超えたトランスミッションを防止するためには、早期かつ正確な診断が不可欠です。COVID-19の大流行は、強固な疾病サーベイランスシステムの重要性を浮き彫りにし、コンパニオンアニマルと家畜の両方の診断インフラへの投資拡大につながった。獣医分子診断学は、人獣共通感染症の病原体を迅速かつ正確に検出するツールを提供することで、この取り組みにおいて重要な役割を果たしており、疾病の蔓延を追跡・制御する取り組みを支援しています。この動向は、北米や欧州など家畜の数が多い地域で特に顕著であり、鳥インフルエンザ、牛結核、アフリカ豚熱などの疾病を監視するために分子診断が用いられています。包括的な疾病サーベイランスとバイオセキュリティ対策に対する需要の高まりは、官民両部門における分子診断薬の採用を引き続き促進し、動物の健康管理における重要な手段としての役割を強化すると予想されます。

獣医分子診断学世界市場の成長を促進する要因は？

世界の獣医分子診断学市場の成長は、診断技術の進歩、動物ヘルスケアへの投資の増加、人獣共通感染症に対する意識の高まりなど、いくつかの要因によって牽引されています。主な成長要因のひとつは、ペット人口の拡大とペットの人間化であり、飼い主は動物を家族の一員として扱い、高度なヘルスケアサービスへの投資を厭わないです。このため、迅速かつ正確な結果を提供し、早期診断と効果的な治療を可能にする診断検査に対する需要が急増しています。ユーザーフレンドリーで自動化された分子診断プラットフォームの開拓により、動物病院やクリニックはこれらの検査を日常的な診断業務に組み込むことが容易になり、市場の成長をさらに後押ししています。農家や生産者が牛群の健康状態、生産性、疾病管理を改善しようとしているため、家畜管理における分子診断の利用が増加していることも主要な促進要因です。

感染症の発生率が上昇し、効果的な疾病管理・コントロールの必要性が高まっていることも重要な促進要因です。鳥インフルエンザ、アフリカ豚熱、犬パルボウイルスなどの疾病の発生は、疾病の蔓延を防ぎ経済的損失を最小限に抑えるための迅速かつ正確な診断の重要性を浮き彫りにしています。獣医分子診断学は、病原体の検出と鑑別に信頼性の高いソリューションを提供し、獣医師がタイムリーで的を絞った介入を実施できるようにします。また、抗菌薬耐性（AMR）に対する関心の高まりも市場の成長に寄与しています。分子診断薬は耐性遺伝子を特定し、抗生物質の適切な使用を導くことで、耐性発現のリスクを低減することができるからです。さらに、特にアジア太平洋やラテンアメリカなどの新興市場における動物用診断研究所や研究機関の拡大が、市場成長の新たな機会を生み出しています。これらの地域では、獣医学インフラの近代化と高度な診断技術へのアクセスの改善に投資しているため、世界の獣医分子診断学市場は、技術革新、進化するヘルスケア慣行、動物と公衆衛生に対する意識の高まりのダイナミックな相互作用によって、持続的な拡大が見込まれています。

調査対象企業の例（全42件）

  • BIOMEDICA Medizinprodukte GmbH & Co., KG
  • Bioneer Corporation
  • HealthGene Corporation
  • Idexx Laboratories, Inc.
  • Novacyt Group
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
  • Vca, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16891

Global Veterinary Molecular Diagnostics Market to Reach US$984.2 Million by 2030

The global market for Veterinary Molecular Diagnostics estimated at US$596.5 Million in the year 2023, is expected to reach US$984.2 Million by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$342.8 Million by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$156.7 Million While China is Forecast to Grow at 11.0% CAGR

The Veterinary Molecular Diagnostics market in the U.S. is estimated at US$156.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$238.9 Million by the year 2030 trailing a CAGR of 11.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Veterinary Molecular Diagnostics Market - Key Trends & Growth Drivers Explored

Why Are Veterinary Molecular Diagnostics Revolutionizing Animal Health Management?

Veterinary molecular diagnostics have emerged as a transformative tool in animal healthcare, enabling precise and rapid detection of diseases at the molecular level. But what makes these diagnostic methods so essential in modern veterinary practices? Veterinary molecular diagnostics are advanced testing techniques that identify genetic material, such as DNA and RNA, from pathogens, tumors, or genetic disorders in animals. These tests include polymerase chain reaction (PCR), real-time PCR, next-generation sequencing (NGS), and microarrays, among others, which can detect and quantify pathogens, genetic mutations, or biomarkers with high sensitivity and specificity. By targeting the genetic basis of diseases, these diagnostics allow veterinarians to diagnose conditions early, often before clinical symptoms appear, providing a crucial window for timely intervention and treatment.

The demand for veterinary molecular diagnostics is driven by the growing prevalence of zoonotic diseases, the rising incidence of chronic and infectious conditions in animals, and the increasing focus on preventive healthcare. These diagnostics are widely used in the detection of infectious diseases such as parvovirus, feline leukemia, and bovine respiratory disease, as well as for genetic screening in breeding programs to prevent the transmission of hereditary disorders. Molecular diagnostics have also become indispensable in the field of oncology, where they are used to identify specific mutations and biomarkers that can guide targeted therapies for cancer treatment. Furthermore, the ability to differentiate between closely related pathogens and detect multiple pathogens in a single test has made molecular diagnostics a preferred choice in complex cases where traditional testing methods may fall short. As pet owners, livestock managers, and veterinarians seek more accurate and reliable diagnostic solutions, veterinary molecular diagnostics are poised to play an increasingly central role in animal health management.

How Are Technological Advancements Elevating the Performance of Veterinary Molecular Diagnostics?

The veterinary molecular diagnostics market has experienced significant technological advancements that have enhanced the precision, speed, and accessibility of these diagnostic tools. But what are the key innovations driving these developments? One of the most impactful advancements is the evolution of real-time PCR (qPCR) technology. qPCR has become a gold standard in veterinary diagnostics due to its ability to amplify and quantify DNA or RNA sequences in real-time, providing rapid and highly sensitive results. Modern qPCR systems are equipped with multiplexing capabilities, allowing the simultaneous detection of multiple pathogens or genetic markers in a single sample. This innovation has significantly reduced turnaround times and the need for multiple tests, enabling veterinarians to make quicker and more informed decisions. Additionally, the integration of automated sample preparation systems has streamlined the workflow, reducing the potential for human error and increasing the consistency and reliability of test results.

Another critical innovation is the advent of next-generation sequencing (NGS) technology, which has revolutionized the field of veterinary genomics. NGS allows for comprehensive genetic analysis by sequencing entire genomes or targeted regions of interest, providing insights into complex genetic traits, disease mechanisms, and microbial communities. This technology is being increasingly used in research and clinical settings for applications such as pathogen discovery, antimicrobial resistance monitoring, and cancer genotyping. The development of portable and point-of-care molecular diagnostic devices has further expanded the reach of these technologies, enabling veterinarians to conduct testing on-site, whether in clinics, farms, or field settings. These devices are designed to be user-friendly, requiring minimal training and infrastructure, making advanced molecular diagnostics accessible even in remote or resource-limited environments. Furthermore, advancements in bioinformatics and data analytics have enhanced the interpretation of molecular diagnostic results, allowing for more accurate and actionable insights. These technological innovations have collectively elevated the performance and utility of veterinary molecular diagnostics, making them indispensable tools for modern veterinary medicine.

What Market Trends Are Driving the Adoption of Veterinary Molecular Diagnostics Across Animal Healthcare?

Several emerging market trends are shaping the adoption of veterinary molecular diagnostics across the animal healthcare sector, reflecting the evolving needs and expectations of veterinarians, researchers, and pet owners. One of the most prominent trends is the increasing focus on preventive care and early disease detection. As pet owners and livestock managers become more aware of the benefits of early diagnosis, there is a growing demand for diagnostic tools that can detect diseases at the subclinical stage, before they become symptomatic or spread to other animals. Veterinary molecular diagnostics, with their high sensitivity and specificity, are well-suited for this purpose, allowing for the early identification of infectious agents, genetic disorders, and cancerous cells. This trend is particularly strong in the companion animal sector, where regular health screenings and wellness programs are becoming more common. The ability to detect genetic predispositions and infectious diseases early enables veterinarians to implement targeted preventive measures and develop personalized treatment plans, improving health outcomes and reducing the long-term costs of care.

Another key trend driving the adoption of veterinary molecular diagnostics is the rising prevalence of zoonotic diseases and the need for effective disease surveillance. Zoonotic diseases, which are transmitted between animals and humans, pose a significant public health risk, making early and accurate diagnosis essential for controlling outbreaks and preventing cross-species transmission. The COVID-19 pandemic has underscored the importance of robust disease surveillance systems, leading to increased investment in diagnostic infrastructure for both companion animals and livestock. Veterinary molecular diagnostics are playing a critical role in this effort by providing tools that can detect zoonotic pathogens rapidly and accurately, supporting efforts to track and control disease spread. This trend is particularly evident in regions with large livestock populations, such as North America and Europe, where molecular diagnostics are used to monitor diseases like avian influenza, bovine tuberculosis, and African swine fever. The growing demand for comprehensive disease surveillance and biosecurity measures is expected to continue driving the adoption of molecular diagnostics in both the public and private sectors, reinforcing their role as key instruments in animal health management.

What Factors Are Driving the Growth of the Global Veterinary Molecular Diagnostics Market?

The growth in the global veterinary molecular diagnostics market is driven by several factors, including advancements in diagnostic technology, increasing investment in animal healthcare, and rising awareness of zoonotic diseases. One of the primary growth drivers is the expanding pet population and the humanization of pets, where owners treat their animals as family members and are willing to invest in advanced healthcare services. This has led to a surge in demand for diagnostic tests that provide quick and accurate results, enabling early diagnosis and effective treatment. The development of user-friendly and automated molecular diagnostic platforms has made it easier for veterinary clinics and hospitals to incorporate these tests into their routine diagnostic offerings, further boosting market growth. The increasing use of molecular diagnostics in livestock management is another key growth driver, as farmers and producers seek to improve herd health, productivity, and disease control.

Another significant growth driver is the rising incidence of infectious diseases and the growing need for effective disease management and control. Outbreaks of diseases like avian influenza, African swine fever, and canine parvovirus have highlighted the importance of rapid and accurate diagnostics for preventing disease spread and minimizing economic losses. Veterinary molecular diagnostics provide a reliable solution for detecting and differentiating pathogens, enabling veterinarians to implement timely and targeted interventions. The growing focus on antimicrobial resistance (AMR) is also contributing to market growth, as molecular diagnostics can identify resistance genes and guide the appropriate use of antibiotics, reducing the risk of resistance development. Furthermore, the expansion of veterinary diagnostic laboratories and research institutions, particularly in emerging markets such as Asia-Pacific and Latin America, is creating new opportunities for market growth. As these regions invest in modernizing their veterinary infrastructure and improving access to advanced diagnostic technologies, the global veterinary molecular diagnostics market is poised for sustained expansion, driven by a dynamic interplay of technological innovation, evolving healthcare practices, and increasing awareness of animal and public health.

Select Competitors (Total 42 Featured) -

  • BIOMEDICA Medizinprodukte GmbH & Co., KG
  • Bioneer Corporation
  • HealthGene Corporation
  • Idexx Laboratories, Inc.
  • Novacyt Group
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
  • Vca, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Veterinary Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Infectious Diseases in Companion and Livestock Animals Drives Demand for Veterinary Molecular Diagnostics
    • Increased Adoption of Molecular Diagnostic Techniques in Veterinary Clinics and Laboratories Expands Addressable Market
    • Rising Use of Molecular Diagnostics in Zoonotic Disease Surveillance Sets the Stage for Market Growth
    • Surge in Demand for Molecular Diagnostic Tests in Food Safety and Animal Health Monitoring Expands Market Opportunities
    • Growing Adoption of Molecular Diagnostics in Veterinary Oncology and Genetic Disease Testing Strengthens Business Case
    • Technological Advancements in Multiplex and High-Throughput Molecular Diagnostic Platforms Propel Market Expansion
    • Growing Use of Molecular Diagnostics in Animal Reproductive Health and Fertility Management Strengthens Market Growth
    • Surge in Use of Molecular Diagnostic Techniques in Wildlife and Conservation Medicine Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Instruments & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals/Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals/Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals/Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • JAPAN
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • CHINA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • EUROPE
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • FRANCE
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • GERMANY
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • INDIA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • AFRICA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030

IV. COMPETITION